Stay updated on AK002 in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the AK002 in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the AK002 in Eosinophilic Gastritis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now renders a 403 Forbidden error page, instead of displaying the study record details. This indicates an access restriction to the NCT03496571 entry rather than a change to the study content.SummaryDifference19%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page shows a new revision tag indicating an update to the platform version (v3.6.6), which reflects a backend or UI update and does not affect the study details or participant data.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing v3.6.4. This indicates a routine site update that does not alter the study content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a minor update to the page template or revision history rather than to the study details.SummaryDifference0.0%

- Check87 days agoChange DetectedA new publication citation has been added to the Publications section, referencing a 2024 study on remission with upadacitinib in eosinophilic gastritis and duodenitis. The page revision version was updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check94 days agoChange DetectedUpdated the page revision from v3.6.0 to v3.6.2, indicating a minor maintenance update to the page's version.SummaryDifference0.0%

Stay in the know with updates to AK002 in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 in Eosinophilic Gastritis Clinical Trial page.